Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 3 50-3, 2004, Pages

  Broca, Christophe ^a,b   Breil, Vincent ^c   Cruciani Guglielmacci, Céline ^e   Manteghetti, Michèle ^a   Rouault, Christine ^c   Derouet, Michel ^d   Rizkalla, Salwa ^c   Pau, Bernard ^a   Petit, Pierre ^a   Ribes, Gérard ^a   Ktorza, Alain ^e   Gross, René ^a   Reach, Gérard ^c   Taouis, Mohammed ^d  

^a University of Montpellier I and II   (France)

^b INNODIA SA   (France)

^c INSERM   (France)

^d CEMAGREF   (France)

^e CNRS   (France)

Author keywords

Diabetes; Euglycemic hyperinsulinemic clamp; Insulin resistance; Obesity; Phosphatidylinositol 3 kinase

Indexed keywords

4 HYDROXYISOLEUCINE; INSULIN; INSULIN SENSITIZING AGENT; NEUTRAL INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; HORMONAL REGULATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER METABOLISM; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIET; ENZYME ACTIVATION; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; ISOLEUCINE; LIPIDS; LIVER; MALE; MUSCLE, SKELETAL; NIACINAMIDE; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; SIGNAL TRANSDUCTION; SUCROSE;

EID: 4143074679     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00163.2003     Document Type: Article

References (34)

1. Agheli N, Kadir M, Berni-Canani S, Petitjean E, Boussairi A, Luo J, Bornet F, Slama G, and Rizkalla SW. Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. J Nutr 128: 1283-1288, 1998.
2. Ammon HP and Verspohl E. Pyridine nucleotides in pancreatic islets during inhibition of insulin release by exogenous insulin. Endocrinology 99: 1469-1476, 1976.
3. Anthony JC, Anthony TG, Kimball SR, and Jefferson LS. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr 131: 856S-860S, 2001.
4. Aspinwall CA, Lakey JM, and Kennedy RT. Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 274: 6360-6365, 1999.
5. Broca C, Gross M, Petit P, Sauvaire Y, Manteghetti M, Tournier M, Masiello P, Gomis R, and Ribes G. 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol Endocrinol Metab 277: E617-E623, 1999.
6. Broca C, Manteghetti M, Gross M, Baissac Y, Jacob M, Petit P, Sauvaire Y, and Ribes G. 4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion. Eur J Pharmacol 390: 339-345, 2000.
7. DeFronzo RA. The triumvirate: β-cell, muscle, liver a collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
8. Dupont J, Berouet M, Simon J, and Taouis M. Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3́-kinase activity. Biochem J 335: 293-300, 1998.
9. Fluteau-Nadler S, Rizkalla SW, Luo J, Guerre-Millo M, Luo J, Bruzzo F, and Slama G. Regulation of glucose transporters in muscle and adipocytes of insulin resistant rats: effects of n-3 poly- and mono-unsatured fatty acids (Abstract). Diabetologia 39: A173, 1996.
10. Gao Z, Konrad RJ, Collins H, Matschinsky FM, Rothenberg PL, and Wolf BA. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes 45: 854-862, 1996.
11. Giorgino F, Logoluso F, Davalli AM, Napoli R, Laviola L, Hirshman MF, Horton ES, Weir G, and Smith RJ. Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes 48: 801-812, 1999.
12. Herbert V, Laws KS, Gottlieb CW, and Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375-1365, 1965.
13. Kahn CR. Insulin receptors and insulin signaling in normal and disease states. In: International Textbook of Diabetes Mellitus (2nd ed.), edited by Alberti KGMM, Zimmet P, DeFronzo RA, and Keen H. Philadelphia, PA: Lippincott-Raven, 1997, p. 437-467.
14. Kahn SE and Porte D. Islet dysfunction in non insulin-dependent diabetes mellitus. Am J Med 85: 4-8, 1988.
15. Kergoat M and Portha B. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin: assessment with the insulin-glucose clamp technique. Diabetes 34: 1120-1126, 1985.
16. Levy-Toledano R, Taouis M, Blaettler DH, Gorden P, and Taylor SI. Insulin-stimulated activation of phosphatidyl inositol 3-kinase due to direct binding of the p85 subunit to the C-terminus of the insulin receptor in intact cells. J Biol Chem 269: 31178-31182, 1994.
17. Magnan C, Gilbert M, and Kahn BB. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle. Lipids 31: 1141-1149, 1996.
18. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hilaire-Buys D, Novelli M, and Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229, 1998.
19. May ME and Buse MG. Effects of branched-chain amino acids on protein turnover. Diabetes Metab Rev 5: 227-245, 1989.
20. Pace CS, Matschinsky FM, Lacy PE, and Conant S. Electrophysiological evidence for the autoregulation of beta-cell secretion by insulin. Biochim Biophys Acta 497: 408-414, 1977.
21. Patti ME, Brambilla E, Luzi L, Landaker EJ, and Kahn CR. Bidirectional modulation of insulin action by amino acid. J Clin Invest 101: 1519-1529, 1998.
22. Persaud SJ, Asare-Anane H, and Jones PM. Insulin receptor activation inhibits insulin secretion from human islets of Langerhans. FEBS Lett 510: 225-228, 2002.
23. Previs SF, Withers DJ, Ren JM, White MF, and Shulman GI. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275: 38990-38994, 2002.
24. Raju J, Gupta D, Rao AR, Yadava PK, and Baquer NZ. Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 224: 45-51, 2001.
25. Ribes G, Sauvaire Y, Da Costa C, Baccou JC, and Loubatieres-Mariani MM. Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs. Proc Soc Exp Biol Med 182: 159-166, 1986.
26. Rohner-Jeanrenaud F, Proietto J, Ionescu E, and Jeanrenaud B. Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa rats. Diabetes 35: 1350-1355, 1986.
27. Sauvaire Y, Petit P, Broca C, Manteghetti M, Baissac Y, Gross R, Roye M, Leconte A, Gorais R, and Ribes G. 4-Hydroxyisoleucine, a novel amino acid potentiator of insulin secretion. Diabetes 47: 206-210, 1998.
28. Schatz H and Pfeiffer EF. Release of immunoreactive and radioactively prelabelled endogenous (pro)-insulin from isolated islets of rat pancreas in the presence of exogenous insulin. J Endocrinol 74: 243-249, 1977.
29. Scott PH, Brunn GJ, Kohn AD, Roth RA, and Lawrence JC. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci USA 95: 7772-7777, 1998.
30. Shafrir E. Diabetes in animals. In: Diabetes Mellitus: Theory and Practice, edited by Rifkin H and Porte D Jr. New York: Elsevier, 1990, p. 299-340.
31. Taouis M, Broca C, Masiello P, Roye M, Manteghetti M, Derouet M, Gross R, and Ribes G. Delayed occurrence of insulin resistance in a new experimental model of NIDDM (Abstract). Diabetologia 41: A198, 1998.
32. White MF. The insulin signalling system and the IRS proteins. Diabetologia 40: S2-S17, 1997.
33. Yang C, Chang TJ, Chang JC, Liu MW, Tai TY, Hsu WH, and Chuang LM. Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. Diabetes 50: 2598-2602, 2001.
34. Youn HJ, Kim JK, and Buchanan TA. Time course of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection. Diabetes 43: 564-571, 1994.